FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to maxillofacial surgery. Autolipotransplant used is a microlipotransfer with particle size of 0.5–0.7 mm, obtained from a pre-purified autologous graft by physiological movement by two 10-ml syringe through a special adapter with a hole diameter of 0.7–1.2 mm 30-50 times. That is followed by administering the isolated microlipotransfer into the soft tissue atrophic scars.
EFFECT: method enables reducing the traumatism of the method by avoiding additional incisions, reducing the length of rehabilitation, improving the aesthetic effect due to improved quality of the skin and absence of additional scars.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS WITH ATROPHIC SCARS | 2023 |
|
RU2825873C1 |
| METHOD FOR CORRECTING SKIN DEFECTS | 2020 |
|
RU2744966C1 |
| METHOD FOR TREATING HEAD AND NECK HYPERTROPHIC AND KELOID SCARS | 2020 |
|
RU2744669C1 |
| METHOD FOR SURGICAL REMOVAL OF CUTANEOUS SCAR DEFORMATIONS | 2003 |
|
RU2254071C1 |
| METHOD OF SOFT TISSUE DEFECT CORRECTION | 2019 |
|
RU2722050C1 |
| METHOD OF SINGLE-STEP ELIMINATION OF DEFECTS OF ORAL CAVITY FLOOR AND TONGUE SURFACE | 2018 |
|
RU2677793C1 |
| METHOD OF TREATING TROPHIC ULCERS | 2013 |
|
RU2528973C1 |
| METHOD OF TREATING THE PATIENTS WITH SCARRING SKIN LESIONS | 2019 |
|
RU2712183C1 |
| RADIO-FREQUENCY CURRENT BIOREINFORCING OF ATROPHIC SKIN | 2008 |
|
RU2372872C1 |
| METHOD OF TREATING SKIN FIBROSIS | 2021 |
|
RU2817948C2 |
